Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Passed on 3/10/26
Summary
Amendment can translate this bill from legal jargon into easy-to-understand language. Sign up to try it for free.
- Takes 30 seconds
- Free
- No credit card required
Sponsors
DDDD
4
9
RRRRRRRRR
Democratic CaucusRepublican Caucus
Roll Call Votes
21 Yea
RRRRRDRRRRDRRRRDRRRRR12 Nay
RRRRRRRRRRRR2 Absent
RRCalendar
Feb 5
12:00 AM
House Health and Human Services Hearing
Feb 25
12:00 AM
Senate Health and Human Services Hearing